Twelve-month outcomes of ranibizumab for diabetic macular edema in routine clinical practice in Mexico

Revista Mexicana de Oftalmología (English Edition) Pub Date : 2019-09-02 DOI:10.24875/rmoe.m19000080

L. P. Orozco-Gómez, Leonor Hernández-Salazar, Vanesa Flores-Peredo, Alma L. Ortega-Villalobos, Sergio Aranda-Serna, Luis Gerardo-Ferreyra, Elisa Pérez-González, Julio Pérez-Monjaraz, Alejandra Sabina Ruiz-Franco

{"title":"Twelve-month outcomes of ranibizumab for diabetic macular edema in routine clinical practice in Mexico","authors":"L. P. Orozco-Gómez, Leonor Hernández-Salazar, Vanesa Flores-Peredo, Alma L. Ortega-Villalobos, Sergio Aranda-Serna, Luis Gerardo-Ferreyra, Elisa Pérez-González, Julio Pérez-Monjaraz, Alejandra Sabina Ruiz-Franco","doi":"10.24875/rmoe.m19000080","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate visual acuity (VA) and central retinal thickness (CRT) outcomes in patients treated with ranibizumab for diabetic macular edema (DME) in a clinical setting in Mexico. Methods: A prospective, open-label, single arm study was performed on 48 eyes of 34 patients with center-involving DME at four high-specialty ISSSTE hospitals in Mexico. Patients Correspondencia: *Alejandra Sabina Ruiz-Franco Calz. Gral. Ignacio Zaragoza, 1711 Col. Ejército Constitucionalista C.P. 09220, Iztapalapa, Ciudad de México, México E-mail: asruiz222@gmail.com Disponible en internet: 01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx Fecha de recepción: 04-05-2019 Fecha de aceptación: 20-06-2019 DOI: 10.24875/RMO.M19000085 0187-4519/© 2019 Sociedad Mexicana de Oftalmología. Publicado por Permanyer México. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 19 L.P. Orozco-Gómez, et al.: Resultados del ranibizumab en el edema macular diabético","PeriodicalId":348732,"journal":{"name":"Revista Mexicana de Oftalmología (English Edition)","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Mexicana de Oftalmología (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/rmoe.m19000080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To evaluate visual acuity (VA) and central retinal thickness (CRT) outcomes in patients treated with ranibizumab for diabetic macular edema (DME) in a clinical setting in Mexico. Methods: A prospective, open-label, single arm study was performed on 48 eyes of 34 patients with center-involving DME at four high-specialty ISSSTE hospitals in Mexico. Patients Correspondencia: *Alejandra Sabina Ruiz-Franco Calz. Gral. Ignacio Zaragoza, 1711 Col. Ejército Constitucionalista C.P. 09220, Iztapalapa, Ciudad de México, México E-mail: asruiz222@gmail.com Disponible en internet: 01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx Fecha de recepción: 04-05-2019 Fecha de aceptación: 20-06-2019 DOI: 10.24875/RMO.M19000085 0187-4519/© 2019 Sociedad Mexicana de Oftalmología. Publicado por Permanyer México. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Si n co nt ar c on e l c on se nt im ie nt o pr ev io p or e sc ri to d el e di to r, no p od rá r ep ro du ci rs e ni f ot oc op ia rs e ni ng un a pa rt e de e st a pu bl ic ac ió n. © P er m an ye r 20 19 L.P. Orozco-Gómez, et al.: Resultados del ranibizumab en el edema macular diabético

查看原文本刊更多论文

在墨西哥常规临床实践中，雷尼单抗治疗糖尿病黄斑水肿的12个月结果

目的:评估雷尼比单抗治疗糖尿病黄斑水肿(DME)患者的视力(VA)和中央视网膜厚度(CRT)结果。方法:对墨西哥四家高专科ISSSTE医院34例emd患者的48只眼睛进行了前瞻性、开放式、单臂研究。患者通信:*Alejandra Sabina ruz - franco Calz。Gral. Ignacio Zaragoza, 1711 Col. ejercito Constitucionalista C.P. 09220, Iztapalapa, Ciudad de mexico, mexico E-mail: asruiz222@gmail.com互联网:01-09-2019 Rev Mex Oftalmol. 2019;93(5):238-245 www.rmo.com.mx接收日期:04-05-2019接受日期:20-06-2019 DOI: 10.24875/RMO。M19000085 0187-4519/©2019墨西哥眼科学会。由Permanyer mexico出版。这是一篇在CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/)许可下开放获取的文章。如果n co nt ar c on l和c on nt im ie nt要么pr ev p或e sc ri to d e di答,不p 4.20 rár ep ro du rs e或f cl ot的ol op的rs和pa rt和ng和st维尼《基本法》ic ac ión .©p er惯例研究生Orozco-Gómez 19 20 m an ye r, et al .:糖尿病黄斑水肿的ranibizumab结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Mexicana de Oftalmología (English Edition)

自引率

0.00%

发文量